IslaRobertson

Associate

London + 44.20.7039.5343

Connect:

Share

Experience

  • Bridge to Life announces first close of $56 million growth financingJones Day advised Bridge to Life, Ltd. in its $56 million capital raise consisting of a secured credit facility and a Series A preferred equity investment.
  • Belfius Bank, ING Belgium, and Global Loan Agency Services Limited provide financing for acquisition of Wall!Supply by Grandeco Wallfashion GroupJones Day acted as legal counsel to Belfius Bank SA/NV and ING Belgium SA/NV, as lenders, and Global Loan Agency Services Limited, as agent, in connection with the financing of the acquisition of Wall!Supply by the Grandeco Wallfashion Group.
  • ABM amends and extends existing $1.95 billion credit facilityJones Day represented ABM Industries Incorporated, a leading provider of facility solutions, in connection with an amendment and extension to its existing $1.95 billion credit facility with Bank of America, N.A., as administrative agent.
  • M. Safra & Co. sells 30 Fenchurch Street (formerly known as One Plantation Place) to Brookfield Asset ManagementJones Day represented M. Safra & Co. in the family office's disposal of 30 Fenchurch Street (formerly known as One Plantation Place), one of the largest office developments in the City of London, to funds managed by Brookfield Asset Management.
  • Delancey and APG Joint Venture acquires Earls Court for £425 millionJones Day represented Earls Court Investment Holdings Ltd, a subsidiary of a joint venture between a fund advised by Delancey and APG on behalf of its pension fund clients, in connection with its £425 million acquisition of EC Group Holdings Limited from a subsidiary of Capital & Counties Properties Plc.
    • View All

    Before sending, please note:

    Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.